Drug Shortage Report for LUTREPULSE PWS 0.8MG/VIAL

Last updated on 2024-10-01 History
Report ID 220371
Drug Identification Number 02046210
Brand name LUTREPULSE PWS 0.8MG/VIAL
Common or Proper name GONADORELIN ACETATE
Company Name FERRING INC
Market Status MARKETED
Active Ingredient(s) GONADORELIN ACETATE
Strength(s) 0.8MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS INTRAVENOUS
Packaging size 1 x 10 mL vial of 0.8 mg
ATC code H01CA
ATC description HYPOTHALAMIC HORMONES
Reason for shortage Other (Please describe in comments)
Anticipated start date 2024-06-30
Actual start date 2024-06-30
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2024-10-01
Company comments Lutrapulse 0.8mg is no longer available worldwide beyond June 30, 2024 due to expiry dating of existing supply. No new product will be manufactured or is available due to manufacturing line decommissioning.
Health Canada comments
Tier 3 Status No
Contact Address 200 YORKLAND BLVD
TORONTO, ONTARIO
CANADA M2J 5C1
Company contact information 1-800-263-4057

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2024-10-01 French Compare
v7 2024-10-01 English Compare
v6 2024-07-02 French Compare
v5 2024-07-02 English Compare
v4 2024-07-02 English Compare
v3 2024-07-01 English Compare
v2 2024-02-23 French Compare
v1 2024-02-23 English Compare

Showing 1 to 8 of 8